A Trial to Evaluate the Safety and Usability of the SB15 PFS in Trial Participants With AMD, Macular Oedema Secondary to RVO, or Diabetic Macular Oedema (clinicaltrials.gov) - Sep 29, 2026 - P2 | N=33 | Active, not recruiting | Sponsor: Samsung Bioepis Co., Ltd.
New P2 trial • Age-related Macular Degeneration • Diabetic Macular Edema • Macular Degeneration • Macular Edema • Ophthalmology • Retinal Disorders • Retinal Vein Occlusion • Wet Age-related Macular Degeneration
|